Skip to main content
. Author manuscript; available in PMC: 2015 Nov 15.
Published in final edited form as: Eur J Pharmacol. 2014 Sep 17;743:48–52. doi: 10.1016/j.ejphar.2014.09.008

Fig. 4.

Fig. 4

The time-course of antinociception produced after i.t. administration of MMG22 (1 or 10 nmol) in tumor-bearing mice on PID 21. The half-maximal dose effect for 10 nmol was 24 h, whereas mice receiving 1 nmol exhibited half-maximal effect at 4 h. (n = 5/group; **P < 0.01 and ****P < 0.0001